Regenerative medicine in multiple sclerosis: Identifying pharmacological targets of adult neural stem cell differentiation
- 30 September 2011
- journal article
- review article
- Published by Elsevier in Neurochemistry International
- Vol. 59 (3) , 329-332
- https://doi.org/10.1016/j.neuint.2011.01.017
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Discovery of notch-sparing gamma-secretase inhibitors.Current Alzheimer Research, 2010
- The secretases: enzymes with therapeutic potential in Alzheimer diseaseNature Reviews Neurology, 2010
- Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNSGenes & Development, 2009
- Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and agingGlia, 2009
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple SclerosisNew England Journal of Medicine, 2008
- RAR and RXR modulation in cancer and metabolic diseaseNature Reviews Drug Discovery, 2007
- Mining the Wnt pathway for cancer therapeuticsNature Reviews Drug Discovery, 2006
- Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNSMolecular and Cellular Neuroscience, 2004
- Premyelinating Oligodendrocytes in Chronic Lesions of Multiple SclerosisNew England Journal of Medicine, 2002
- Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axonsBrain, 2000